Navigation Links
Sub-Sahara Africa: Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs
Date:2/20/2017

CAPE TOWN, South Africa, Feb. 20, 2017 /PRNewswire/ -- There has been a paradigm shift in the burden of illness and non-communicable diseases (NCDs) across sub-Saharan Africa, which in turn is driving the demand for chronic prescription drugs. The growing incidence of more Western lifestyle diseases such as cardiovascular disease (CVD), cancer, diabetes and respiratory disease, in addition to infectious and parasitic illness, will present the pharmaceutical industry in Africa with a business opportunity of $40.8 billion in 2019.

"An increase in health spending will encourage local manufacture of drugs," said Transformational Health Research Analyst Saravanan Thangaraj. "We expect this increase in local formulation and filling to be protected by regulatory and tariff barriers, so international players will be looking for local contract manufacturers and other strategic partnerships."

African Pharmaceuticals Market, Forecast to 2020, part of Frost & Sullivan's Life Sciences Growth Partnership Service program, provides valuable insights for Big Pharma and generic manufacturers looking to set up manufacturing units in Africa; as well as over-the-counter (OTC) and chronic disease therapeutics manufacturers; large, local enterprises in Kenya and Nigeria; and Tier 1 distributors. In addition to a brief competitive overview, the research details the pricing and regulatory environment, revenues and growth forecasts, as well as market dynamics—particularly challenges, drivers and restraints. Therapeutic areas covered include haematology, oncology, men's health, central nervous system (CNS), women's health, diabetes, cardiovascular, dermatologicals, gastrointestinals, cough and colds, nutritionals, analgesics and anti-infectives.

Click here for complimentary access to more information on this analysis and to register for a Growth Strategy Dialogue, a free interactive briefing with Frost & Sullivan's thought leaders.

Heavy dependence on price, coupled with complexities associated with public sector tendering, make it difficult for multinationals to compete in this space. The private market, on the other hand, faces challenges with regards to fragmented payer channels between donors, private insurance payers and employers, even as high out-of-pocket expenses restrict patient access to medicines.

Nonetheless, several trends are encouraging investment:
The regulatory environment for manufacturing in East Africa is improving rapidly with increasing regional harmonisation
Pharmaceutical spending in Africa was noted to be growing by 10.6 percent
Out-of-pocket spend on healthcare is increasing
The share of OTC drugs is high, indicative of a culture of self-medication in Nigeria and Kenya
Contribution of NCDs to the healthcare burden in Africa will rise by 21 percent through 2030

"Addressing loopholes in the supply chain and distribution channels is crucial for foreign companies to ensure product availability and prevent circulation of counterfeit drugs," added Thangaraj. "Investing in technical training of distributors and pharmacists, and product-specific initiatives like barcodes and holograms to track counterfeits, can also help minimize drug trafficking and enhance the brand's image."

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

African Pharmaceuticals Market, Forecast to 2020
MC24-52

Contact:
Samantha James
Corporate Communications – Africa
P: +27 21 680 3574
F: +27 21 680 3296
E: samantha.james@frost.com

http://ww2.frost.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sub-sahara-africa-increase-in-western-lifestyles-leads-to-dire-need-for-chronic-prescription-drugs-300409967.html


'/>"/>
SOURCE Frost & Sullivan
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Malaria No More Honors Aleres Contributions to Diagnosing and Eliminating Malaria in sub-Saharan Africa
2. Frost & Sullivan Applauds MEDITECH as Provider of Best-in-class Healthcare Informatics Products in Sub-Saharan Africa
3. Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa
4. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
5. U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015
6. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
7. New Treatment for Stroke Set to Increase Chances of Recovery
8. Hill-Rom Increases Third Quarter 2013 Dividend
9. For Multiple Sclerosis Treatment, Prescriber Base for Genzymes Aubagio Among U.S. Neurologists Has Increased Significantly at Six Months Post-launch, Compared to One and Three Months Post-launch
10. ResMed Launches SleepSeeker Online Tool to Increase Patient Engagement in Therapy for Sleep-Disordered Breathing
11. DebMed to Display Clients Increased Hand Hygiene Compliance Rates and Worlds First Monitored Point-of-Care Dispenser at APIC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... KNOXVILLE, Tenn. , March 23, 2017 /PRNewswire/ ... ("Provectus" or the "Company"), a clinical-stage oncology and ... previously announced Definitive Financing Commitment Term Sheet (the ... with a group of the Company,s stockholders, who ... "PRH Group" in a Form 8-K filed with ...
(Date:3/23/2017)... March 23, 2017 The key factors ... increasing diabetic population, accelerating economic growth and increasing healthcare expenditure. ... are higher life expectancy of ESRD patients, rising demand for ... However, the expansion of the market is hindered by high ... ...
(Date:3/23/2017)... -- As a result of diagnostic technology increasing ... allergic diseases, cutting edge developments in targeted drugs ... in which pharmaceutical and biotech companies are addressing ... both a high quality meeting and a platform ... research scholars and doctors. The event will also ...
Breaking Medicine Technology:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Nursing Society (ONS) wanted to create a communications platform that positions them as ... goal, Elliance and ONS reinvented their online publication as an always-on, always-fresh news, ...
(Date:3/24/2017)... ... March 24, 2017 , ... On ... Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will present ... majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... ... Viewers who like to educate themselves on current issues and who enjoy ... societal issues tend to appreciate and love the "Informed" series, hosted by Rob Lowe. ... for causes around the world. , Running for charity has become a ...
(Date:3/24/2017)... Southlake, Texas (PRWEB) , ... March 24, 2017 ... ... make 2017 the year of enhancements, upgrading their training and leads programs. , ... Empower University. Reserved for elite sales agents, Performance Partners is designed to teach ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding ... God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with ... Walk with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, ...
Breaking Medicine News(10 mins):